Pectoral Nerve Block II and Erector Spine Plane Block in Breast Cancer Surgery
CompletedNot applicableNCT04135157
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates the analgesic effects of pectoralis nerve block (PECS II) and erector spinae plane block (ESP) in patients having segmental mastectomy and sentinel lymph node biopsy (SLNB). Each one-third of patients will have ESP block and pectoralis nerve block (PECS II) 30 min before general anesthesia , while other one-third of patients will have only general anesthesia.
Study details
- Official title
- Research of the Effects of Pectoralis Nerve Block II and Erector Spina Plan Block in Breast Cancer Surgery
- Conditions
- Anesthesia
- Analgesia
- Acute Pain
- Chronic Pain
- Pectoralis Nerve Block
- Erector Spine Plane Block
- Patient Controlled Analgesia
- Interventions
- Procedure: Pectoralis nerve block II
- Procedure: Erector spine plane block
- Other: Control
- Sponsor
- Ondokuz Mayıs University
- Collaborators
- CENGİZ KAYA (ckaya)
- Start date
- 2019-07-01
- Primary completion
- 2020-09-01
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ASA 1-2 patients between the age of 18-65, scheduled for elective unilateral segmental mastectomy + sentinel lymph node biopsy Exclusion Criteria: * Age \<18 or\> 65, ASA 3-4 patients * Obesity (\> 100 kg, BMI\> 35 kg / m2) * Patients undergoing bilateral mastectomy * Pregnancy * Contraindication of regional anesthesia (coagulopathy, abnormal INR, thrombocytopenia, infection at the injection site) * Serious renal, cardiac, hepatic disease * Hypersensitivity to local anesthetics or a history of allergy * Patients with a history of opioid use longer than four weeks * Patients with psychiatric disorders or communication difficulties * Patients with chest deformity * Patients with previous breast surgery except diagnostic biopsies * Patients who do not want to participate
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04135157